Nearly 1,000 Cyclists Will Ride to Stop Diabetes at Indianapolis Motor Speedway

Key points
- In 10 days, nearly 1,000 cyclists from 16 states will converge on the Indianapolis Motor Speedway to ride their bicycles in the movement to Stop DiabetesSM.
- The American Diabetes Association is leading the fight against the deadly consequences of diabetes and fighting for those affected by diabetes.
- The Indiana Tour de Cure features a 100-mile Track Challenge, 50K and 75K Road Rides and a Recreational Family Track Ride at the Indianapolis Motor Speedway just two weeks after the world-famous 2010 Indianapolis 500 race.
- Tour de Cure is a series of fundraising cycling events held in 43 states nationwide to benefit the American Diabetes Association.
In 10 days, nearly 1,000 cyclists from 16 states will converge on the Indianapolis Motor Speedway to ride their bicycles in the movement to Stop DiabetesSM. Their goal: to complete the Indiana Tour de Cure on June 12 and support the research, education and advocacy work of the American Diabetes Association.
The Indiana Tour de Cure features a 100-mile Track Challenge, 50K and 75K Road Rides and a Recreational Family Track Ride at the Indianapolis Motor Speedway just two weeks after the world-famous 2010 Indianapolis 500 race. Registration is open now through June 12 at http://main.diabetes.org/indytour or 317-352-9226, ext. 6731. All rides kick off at 7:30 a.m. on June 12; walk-up registration will be available starting at 6 a.m. on event day at Pagoda Plaza.
Tour de Cure is a series of fundraising cycling events held in 43 states nationwide to benefit the American Diabetes Association. The Tour is a ride, not a race, with routes designed for everyone from the occasional rider to the experienced cyclist. The event strives to combat diabetes by promoting good health through exercise.
Diabetes is a chronic disease with no cure that can lead to serious complications such as heart disease, stroke, blindness, kidney disease, nerve damage and amputations. Diabetes kills more people each year in the U.S. than AIDS and breast cancer combined. It is the sixth leading cause of death in the U.S. and continues to grow at near-epidemic rates.
Diabetes is a serious public health issue in Indiana, which outpaces the national average in prevalence of the disease. More than 714,000 Hoosier children and adults have type 1, type 2 and gestational diabetes (13.6% of Indiana’s population). One in four of these Hoosiers doesn’t know he or she has diabetes. About 1.6 million more Hoosiers have pre-diabetes, which puts them at high risk for type 2 diabetes — a form of the disease that is often preventable. Nationally, nearly 24 million Americans have diabetes and about 57 million have pre-diabetes.
“Tour de Cure is an important part of the Stop Diabetes movement here in Indiana,” said Jennifer Pferrer, Executive Director of the American Diabetes Association – Indiana Area. “Tour de Cure riders raised more than $250,000 in Indianapolis last year to fuel the research, education and advocacy work of the American Diabetes Association. This year’s Tour de Cure riders are helping us strengthen the impact of the Stop Diabetes movement in Indiana through fundraising and awareness.”
Last year, more than 700 cyclists rode in the Indiana Tour de Cure in a collective effort to fight diabetes.
Special thanks to the national sponsors of 2010 Tour de Cure: Gold’s Gym, Performance Bicycle, Splenda and Sun Crystals.
Additional thanks to the local sponsors of this year’s Indiana Tour de Cure: Indianapolis Motor Speedway, Roche Diagnostics, Eli Lilly and Company, McAlister’s Deli, Anthem Blue Cross Blue Shield Foundation, Takeda, WXIN Fox 59, 92.3 WTTS FM and NUVO Newsweekly.
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Diabetes & Hormones →
NewsResearchers find a potential target for the treatment of type 2 diabetes
Currently, there are more than 350 million type 2 diabetics and according to the World Health Organization (WHO) by 2030 it will be the 7th leading cause of death worldwide. The hallmark of type 2 diabetes is insulin…
19 June 2015
NewsWhich artificial pancreas system is the best for children with type 1 diabetes?
A Montréal research team, co-supervised by Dr. Rémi Rabasa-Lhoret from the IRCM and Dr. Laurent Legault from the Montreal Children's Hospital, undertook the first paediatric outpatient study to compare three alternative…
11 June 2015
NewsA step towards a type 1 diabetes vaccine by using nanotherapy
Two years ago, the Immunology of Diabetes Research Group at the Germans Trias Research Institute (at Universitat Autònoma de Barcelona - Campus of International Excellence Sphere) reported a new experimental…






